DIGITAL PCR AND REAL TIME PCR (QPCR) MARKET ANALYSIS

Digital PCR and Real-time PCR (qPCR) Market, by Technology (Quantitative PCR and Digital PCR), by Product Type (Reagents and Consumables, and Instruments), by Application (Clinical, Research, and Forensic), by End User (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Industries, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

Key development

In April 2019, Thermo Fisher Scientific Inc. introduced Applied Biosystems QuantStudio 6 and 7 Pro Real-Time PCR Systems, which includes new specifications like facial authentication, voice command and radiofrequency identification.
In January 2019, QIAGEN N.V. announced the development of range of next-generation systems for the digital polymerase chain reaction (digital PCR or dPCR) one of the fastest-growing molecular testing applications, which is expected to launch in 2020.
In 2017, Bio-Rad Laboratories, Inc. introduced iQ-Check Enterobacteriaceae real-time PCR detection kit that can be used for 94 samples.
In 2017, Agilent Technologies Inc. launched AriaDx Real-Time PCR System for Clinical Diagnostics in Europe to expand its molecular diagnostic portfolio.
In 2016, Danaher Corporation acquired Cepheid Inc. to expand its qPCR-product portfolio.